RxDoctor Payments Data

Abdul Shahin

Physician Assistant · Brooklyn, NYNPI 1316314636

Payments from drug & device makers

$8,896in general payments, 2019–2025

Across 377 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$2K
  • AstraZeneca$1K
  • Philips North America LLC$1K
  • AbbVie$1K
  • Novo Nordisk$803
  • Baxter Healthcare$449
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$8,79799%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,896 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide155$280,421
FarxigaDapagliflozin Propanediol211$231,099
Diclofenac Sodium207$213,405
LofenaDiclofenac Potassium17$158,664
JardianceEmpagliflozin137$132,791
Tolectin 600Tolmetin Sodium18$101,913
KerendiaFinerenone150$100,601
Xigduo XrDapaglifloz Propaned/Metformin113$99,634
Tolmetin Sodium31$98,287
SynjardyEmpagliflozin/Metformin Hcl104$85,385
RybelsusSemaglutide55$80,773
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate37$75,507
VascepaIcosapent Ethyl135$68,769
Synjardy XrEmpagliflozin/Metformin Hcl77$63,409
Doxepin Hcl42$49,510

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$803$361,194210 claims
Boehringer IngelheimJardiance, Synjardy, Synjardy Xr$191$281,584318 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,075$248,055239 claims
BayerKerendia$2,019$100,601150 claims
Lilly USA, LLCMounjaro, Trulicity$293$66,78042 claims
Johnson & JohnsonXarelto$159$32,13025 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$448$26,23151 claims
AbbVieLinzess$1,003$23,04532 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →